Prostate-specific antigen (PSA) progression-free survival (PFS): A comparison of degarelix versus leuprolide in patients with prostate cancer. Background: Prostate cancer (PCa) is the second leading ...

Acute gastroenteritis afflicts adults of all ages, causing significant suffering and inflicting significant costs on the American healthcare system. A new study encompassing nearly 40,000 hospital ...

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Panels Market 2025-2029 - Strategies, Trends and Forecasts by Syndrome (Respiratory, Sepsis, Gi, Other), Place, Product and Country, ...

This is an abstract. The full journal study is available to read via the link in the source information below. The implementation of the multiplex PCR ME panel for bacterial meningitis reduced the ...

DUBLIN--(BUSINESS WIRE)--The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country. With Market Analysis ...

Background. Molecular syndromic diagnostic panels can enhance pathogen identification in the approximately 2–4 billion episodes of acute gastroenteritis that occur annually worldwide. However, the ...

There are new generations of comprehensive multiplex molecular panels available for infectious diseases syndromic diagnostics. They are able to rapidly detect and identify the most common pathogens in ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1 ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) with varying capacities to evade vaccine-induced immunity continue to emerge, the latest one being the B.1.1.529 ...

Messenger molecules such as cytokines are involved in the communication within the immune system and play a vital role in a variety of conditions including cancer and autoimmune diseases. Advancing ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced the launch of the Simoa™ Neurology 4-Plex ...

A multicenter study has found that a multiplex diagnostic panel developed by Opgen Inc. can reduce the use of inappropriate antibiotic therapy by 45.1%. Opgen’s Unyvero Hospitalized Pneumonia (HPN) ...